Table 2 Amplification results of the different subject groups: “deleted group”, “carrier group” and “control group”.

From: Newborn screening of duchenne muscular dystrophy specifically targeting deletions amenable to exon-skipping therapy

Subject group

Target DMD exon

Genotyped

Number of patients

Exon 44

Exon 46

Exon 50

Exon 52

Exon 54

Deleted group

Del*

Ampli*

Ampli

Ampli

Ampli

del_13-44

n = 34 (total)

Deleted group

Del

Ampli

Ampli

Ampli

Ampli

del_44

Deleted group

Del

Ampli

Ampli

Ampli

Ampli

del_20-44

Deleted group

Del

Ampli

Ampli

Ampli

Ampli

del_20-44

Deleted group

Ampli

Del

Del

Del

Del

del_46-55

Deleted group

Ampli

Del

Del

Del

Del

del_45-55

Deleted group

Ampli

Del

Del

Del

Del

del_45-55

Deleted group

Ampli

Del

Del

Del

Del

del_45-55

Deleted group

Ampli

Del

Del

Del

Del

del_45-55

Deleted group

Ampli

Del

Del

Del

Ampli

del_46-53

Deleted group

Ampli

Del

Del

Del

Ampli

del 46–52

Deleted group

Ampli

Del

Del

Ampli

Ampli

del_45-50

Deleted group

Ampli

Del

Del

Ampli

Ampli

del_45-50

Deleted group

Ampli

Del

Del

Ampli

Ampli

del_45-50

Deleted group

Ampli

Del

Del

Ampli

Ampli

del_45-50

Deleted group

Ampli

Del

Del

Ampli

Ampli

del_45-50

Deleted group

Ampli

Del

Del

Ampli

Ampli

del_45-50

Deleted group

Ampli

Del

Del

Ampli

Ampli

del_45-50

Deleted group

Ampli

Del

Ampli

Ampli

Ampli

del_45-47

Deleted group

Ampli

Del

Ampli

Ampli

Ampli

del_45-47

Deleted group

Ampli

Del

Ampli

Ampli

Ampli

del_45-47

Deleted group

Ampli

Del

Ampli

Ampli

Ampli

del_45-46

Deleted group

Ampli

Del

Ampli

Ampli

Ampli

del_46-48

Deleted group

Ampli

Del

Ampli

Ampli

Ampli

del_45-48

Deleted group

Ampli

Del

Ampli

Ampli

Ampli

del_45-48

Deleted group

Ampli

Ampli

Del

Del

Del

del_48-55

Deleted group

Ampli

Ampli

Del

Del

Del

del_49-54

Deleted group

Ampli

Ampli

Del

Del

Del

del_49-54

Deleted group

Ampli

Ampli

Del

Ampli

Ampli

del_50

Deleted group

Ampli

Ampli

Del

Ampli

Ampli

del_50

Deleted group

Ampli

Ampli

Del

Ampli

Ampli

del_50

Deleted group

Ampli

Ampli

Ampli

Del

Del

del_51-55

Deleted group

Ampli

Ampli

Ampli

Del

Del

del_51-64

Deleted group

Ampli

Ampli

Ampli

Del

Ampli

del_52

Deleted group

Ampli

Ampli

Ampli

Ampli

Ampli

N/Aa

n = 17

Carrier group

Ampli

Ampli

Ampli

Ampli

Ampli

N/Ab

n = 32

Carrier group

Ampli

Ampli

Ampli

Ampli

Ampli

N/Ac

n = 18

Control group

Ampli

Ampli

Ampli

Ampli

Ampli

Normal

n = 19

  1. a = male patients with a DMD deletion not overlapping any of the 5 target exons.
  2. b = female subjects carrying a DMD deletion overlapping at least one of the 5 target exons.
  3. c = female subjects carrying a DMD deletion not overlapping any of the 5 target exons.
  4. d = Deleted exons were identified through MLPA. Intronic breakpoints have not been sequenced; genotypes are reported according to the LOVD-DMD database.
  5. *Results show if the target exon is deleted (Del) or amplified (Ampli).
  6. N/A Not Applicable.